Ferroptosis in the treatment of colorectal cancer

doi:10.16352/j.issn.1001-6325.2023.01.0174

Abstract

Abstract: Ferroptosis is a form of programmed cell death caused by accumulation of iron-dependent lipophilic reactive oxygen species. Its occurrence depends on the comprehensive changes of intracellular iron homeostasis, lipid metabolism and antioxidant system. Colorectal cancer is one of the common malignant tumors of the digestive tract. It can effectively inhibit the proliferation of colorectal cancer cells, reverse drug resistance and improve the radio sensitivity of colorectal cancer cells by inducing ferroptosis pathway.

Key words: colorectal cancer, ferroptosis, cancer treatment, radiation therapy, chemotherapy

CLC Number:

R735.3

ZHUANG Zhicheng, GUAN Guoxian. Ferroptosis in the treatment of colorectal cancer[J]. Basic & Clinical Medicine, 2023, 43(1): 174-177.

References

[1] Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149: 1060-1072.
[2] Yang WS, Stockwell BR. Ferroptosis: Death by lipid peroxidation[J]. Trends Cell Biol, 2016, 26: 165-176.
[3] Vogt AS, Arsiwala T, Mohsen M, et al. On iron metabolism and its regulation[J]. Int J Mol Sci,2021, 22: 4591.doi:10.33890/ijms22094591.
[4] 李莉,赵昱,龚淼,等. 铁过载损伤小鼠睾丸支持细胞[J]. 基础医学与临床, 2016, 36: 321-326.
[5] Sharma A, Flora SJS. Positive and negative regulation of ferroptosis and its role in maintaining metabolic and redox homeostasis[J]. Oxid Med Cell Longev, 2021, 2021: 1-13.
[6] Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor[J]. Nature, 2019, 575: 693-698.
[7] Santana-Codina N, Gikandi A, Mancias JD. The role of NCOA4-mediated ferritinophagy in ferroptosis[J]. Adv Exp Med Biol, 2021, 1301: 41-57.
[8] Lee D, Song M, Kim E. Role of oxidative stress and Nrf2/KEAP1 signaling in colorectal cancer: mechanisms and therapeutic perspectives with phytochemicals[J]. Antioxidants, 2021, 10: 743.doi:10.3390/antiox10050743.
[9] Ploug M, Kroijer R, Qvist N, et al. Iron deficiency in colorectal cancer patients: a cohort study on prevalence and associations[J]. Colorectal Dis, 2021, 23: 853-859.
[10] Haschka D, Hoffmann A, Weiss G. Iron in immune cell function and host defense[J]. Semin Cell Dev Biol, 2021, 115: 27-36.
[11] Harris IS, DeNicola GM. The complex interplay between antioxidants and ROS in cancer[J]. Trends Cell Biol, 2020, 30: 440-451.
[12] Zhang Y, Liu X, Xu M, et al. Prognostic value of pretreatment systemic inflammatory markers in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy[J]. Sci Rep-Uk, 2020, 10: 8017.doi:10.1038/s41598-020-64683-z.
[13] Chen P, Wu J, Ding CC, et al. Kinome screen of ferroptosis reveals a novel role of ATM in regulating iron metabolism[J]. Cell Death Differ, 2020, 27: 1008-1022.
[14] Farhood B, Ashrafizadeh M, Khodamoradi E, et al. Targeting of cellular redox metabolism for mitigation of radiation injury[J]. Life Sci, 2020, 250: 117570.doi:10.1016/j.lfs.2020.117570.
[15] 冯亚辉,蒋胜,涂文玲,等. 电离辐射对皮肤细胞铁死亡的影响及其抑制剂Ferrostatin-1的防护作用研究[J]. 中华放射医学与防护杂志, 2021, 41: 602-608.
[16] Lei G, Zhang Y, Koppula P, et al. The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression[J]. Cell Res,2020, 30: 146-162.
[17] Jiang L, Kon N, Li T, et al. Ferroptosis as a p53-mediated activity during tumoursuppression[J]. Nature, 2015, 520: 57-62.
[18] Kirtonia A, Sethi G, Garg M. The multifaceted role of reactive oxygen species in tumorigenesis[J]. Cell Mol Life Sci,2020, 77: 4459-4483.
[19] Chun K, Kim D, Surh Y. Role of reductive versus oxidative stress in tumor progression and anticancer drug resistance[J]. Cells-Basel, 2021, 10: 758.doi:10.3390/cells10040758.
[20] Yang C, Zhang Y, Lin S, et al. Suppressing the KIF20A/NUAK1/Nrf2/GPX4 signaling pathway induces ferroptosis and enhances the sensitivity of colorectal cancer to oxaliplatin[J]. Aging, 2021, 13: 13515-13534.
[21] Xu X, Zhang X, Wei C, et al. Targeting SLC7A11 specifically suppresses the progression of colorectal cancer stem cells via inducing ferroptosis[J]. Eur J Pharm Sci, 2020, 152: 105450.
[22] Guo J, Xu B, Han Q, et al. Ferroptosis: a novel anti-tumor action for cisplatin[J]. Cancer Res Treat, 2018, 50: 445-460.
[23] Mauri G, Bonazzina E, Amatu A, et al. The evolutionary landscape of treatment for BRAFV600E mutant metastatic colorectal cancer[J]. Cancers, 2021, 13: 137.doi:10.33901/cancers13010137.
[24] Chen P, Li X, Zhang R, et al. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation[J]. Theranostics, 2020, 10: 5107-5119.
[25] Tian X, Li S, Ge G. Apatinib promotes ferroptosis in colorectal cancer cells by targeting ELOVL6/ACSL4 signaling[J]. Cancer Manag Res, 2021, 13: 1333-1342.